Literature DB >> 3056169

Illnesses associated with Escherichia coli O157:H7 infections. A broad clinical spectrum.

P M Griffin1, S M Ostroff, R V Tauxe, K D Greene, J G Wells, J H Lewis, P A Blake.   

Abstract

STUDY
OBJECTIVE: To describe the spectrum of illnesses associated with Escherichia coli O157:H7 infections.
DESIGN: Described an outbreak that showed the broad spectrum of these infections. Reviewed the clinical findings in the other eight major outbreaks reported between 1982 and 1986. Also reviewed reports of sporadic cases.
SETTING: Outbreaks in communities, nursing homes, a day care center, and a kindergarten. CASES: Persons identified in outbreaks of E. coli O157:H7 infections.
RESULTS: Escherichia coli O157:H7 infection causes bloody diarrhea (hemorrhagic colitis), nonbloody diarrhea, the hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. Infection can be asymptomatic, can involve extraintestinal sites, and can be fatal. Bloody diarrhea is the commonest symptom. Most patients have severe abdominal cramps; fever is documented in less than half. Findings from fecal leukocyte examinations often suggest a noninfectious cause. Results of radiologic and colonoscopic examinations can be consistent with a diagnosis of inflammatory bowel disease or ischemic colitis. Patients at the extremes of age are at increased risk for E. coli O157:H7-associated diarrhea, the hemolytic uremic syndrome, thrombotic thrombocytopenic purpura, and death. Antimicrobial agents have not been shown to modify the illness, but there are few data on individual agents.
CONCLUSION: Infection with E. coli O157:H7 should be considered in all patients with bloody diarrhea, the hemolytic uremic syndrome, or thrombotic thrombocytopenic purpura because the infection can masquerade as gastrointestinal bleeding of noninfectious cause, the antecedent diarrhea may be resolved and forgotten by the time the hemolytic uremic syndrome or thrombotic thrombocytopenic purpura is diagnosed, and the detection of E. coli O157:H7 requires specific stool culture techniques.

Entities:  

Mesh:

Year:  1988        PMID: 3056169     DOI: 10.7326/0003-4819-109-9-705

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  187 in total

1.  Rapid detection of enterohemorrhagic Escherichia coli by real-time PCR with fluorescent hybridization probes.

Authors:  T Bellin; M Pulz; A Matussek; H G Hempen; F Gunzer
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

2.  Effect of Shiga toxin 2 on water and ion transport in human colon in vitro.

Authors:  P Fiorito; J M Burgos; M F Miyakawa; M Rivas; G Chillemi; D Berkowski; E Zotta; C Silberstein; C Ibarra
Journal:  Dig Dis Sci       Date:  2000-03       Impact factor: 3.199

3.  Strains of Escherichia coli O157:H7 differ primarily by insertions or deletions, not single-nucleotide polymorphisms.

Authors:  Indira T Kudva; Peter S Evans; Nicole T Perna; Timothy J Barrett; Frederick M Ausubel; Frederick R Blattner; Stephen B Calderwood
Journal:  J Bacteriol       Date:  2002-04       Impact factor: 3.490

4.  Enterohemorrhagic Escherichia coli O157:H7 produces Tir, which is translocated to the host cell membrane but is not tyrosine phosphorylated.

Authors:  R DeVinney; M Stein; D Reinscheid; A Abe; S Ruschkowski; B B Finlay
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

5.  Enterohemorrhagic Escherichia coli virulence regulation by two bacterial adrenergic kinases, QseC and QseE.

Authors:  Jacqueline Njoroge; Vanessa Sperandio
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

6.  Comparison of sorbitol MacConkey agar and a two-step method which utilizes enzyme-linked immunosorbent assay toxin testing and a chromogenic agar to detect and isolate enterohemorrhagic Escherichia coli.

Authors:  T J Novicki; J A Daly; S L Mottice; K C Carroll
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

7.  Probiotic Lactobacillus reuteri ameliorates disease due to enterohemorrhagic Escherichia coli in germfree mice.

Authors:  Kathryn A Eaton; Alexander Honkala; Thomas A Auchtung; Robert A Britton
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

8.  Bacteria-host communication: the language of hormones.

Authors:  Vanessa Sperandio; Alfredo G Torres; Bruce Jarvis; James P Nataro; James B Kaper
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-07       Impact factor: 11.205

9.  Plant cell-based intimin vaccine given orally to mice primed with intimin reduces time of Escherichia coli O157:H7 shedding in feces.

Authors:  Nicole A Judge; Hugh S Mason; Alison D O'Brien
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

10.  Role of hha and ler in transcriptional regulation of the esp operon of enterohemorrhagic Escherichia coli O157:H7.

Authors:  Vijay K Sharma; Richard L Zuerner
Journal:  J Bacteriol       Date:  2004-11       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.